![Thomas Englese](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Englese
Corporate Officer/Principal chez
TONIX PHARMACEUTICALS HOLDING CORP.
Fortune : 9 785 $ au 31/08/2026
Profil
Mr. Thomas J.
Englese is a Chief Commercial Officer at Tonix Pharmaceuticals Holding Corp.
He is on the Board of Directors at Therakos (UK) Ltd. Mr. Englese was previously employed as a Chief Commercial Officer by Elutia, Inc., a General Manager-North America Hospital Therapies by Mallinckrodt Plc, a Vice President-Customer Operations by Ikaria, Inc., a Senior Director-Business Operations by Baxter International, Inc., and a Chief Commercial Officer by Tris Pharma, Inc. He received his undergraduate degree from Villanova University and an MBA from The Pennsylvania State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/09/2026 | 694 ( 0,01 % ) | 9 785 $ | 31/08/2026 |
Postes actifs de Thomas Englese
| Sociétés | Poste | Début |
|---|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Corporate Officer/Principal | 10/09/2024 |
Therakos (UK) Ltd.
 Therakos (UK) Ltd. Medical/Nursing ServicesHealth Services Develops immune cell therapies delivered through extracorporeal photopheresis | Directeur/Membre du Conseil | 30/10/2015 |
Anciens postes connus de Thomas Englese
| Sociétés | Poste | Fin |
|---|---|---|
| MALLINCKRODT PLC | Corporate Officer/Principal | 01/07/2019 |
| IKARIA, INC. | Corporate Officer/Principal | 01/03/2015 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/2008 |
Tris Pharma, Inc.
 Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Corporate Officer/Principal | - |
| ELUTIA INC. | Corporate Officer/Principal | - |
Formation de Thomas Englese
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Ikaria, Inc.
 Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tonix Pharmaceuticals Holding Corp.
 Tonix Pharmaceuticals Holding Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics & diagnostics products to treat and prevent human disease and alleviate suffering | Health Technology |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Health Technology |
Therakos (UK) Ltd.
Therakos (UK) Ltd. Medical/Nursing ServicesHealth Services Develops immune cell therapies delivered through extracorporeal photopheresis | Health Services |
Elutia, Inc.
 Elutia, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops customized tissue products | Health Technology |
